[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Tsuruga to OK Monju reactor renovation after top court ruling
Index:
Tsuruga to OK Monju reactor renovation after top court ruling
Lab Scandal Hurts U. of Calif. Contract
US urges firms to make "dirty bomb" treatment
======================================
Tsuruga to OK Monju reactor renovation after top court ruling
TSURUGA, Japan, Feb. 3 (Kyodo) - The city of Tsuruga will give the go-
ahead to renovate the trouble-mired Monju fast-breeder nuclear
reactor after the Supreme Court clears the reactor of safety
concerns, Mayor Kazuharu Kawase said Monday.
The move comes in the wake of the central government's decision on
Friday to appeal a Nagoya High Court decision nullifying its 1983
approval to build the plutonium-producing reactor in the Fukui
Prefecture city.
While expressing disappointment with the high court ruling, Kawase
said the reactor may not be built in the city if the top court judges
that the reactor poses significant safety threats, suggesting a delay
in the city's approval.
The reactor began operations in August 1995, but was shut down after
a sodium coolant leak from the facility sparked a fire in December
that year.
As part of the government's move to restart the reactor, the Ministry
of Economy, Trade and Industry approved last December a plan by the
state-run Japan Nuclear Cycle Development Institute to renovate Monju
with a view to reactivating it.
Kawase did not say exactly when the city's approval, which a reactor
operator had requested by March, would come, saying, ''We'll study
discussions by the city assembly and a prefecture panel on the
subject.''
''We invited the facility convinced that the state has taken safety
measures. But if the appeals court deems its safety level extremely
low, then we can't let Monju remain in our community,'' Kawase said.
However, he noted the central role the reactor occupies in the
nuclear fuel recycling project for a country without significant
natural resources.
''Our city can contribute greatly to research and development''
related to the energy recycling project centered on fast-breeders
like Monju, Kawase said.
Monju, a government-designed 280-megawatt reactor, can create more
plutonium than it consumes and was to play a key role in the national
policy of recycling spent nuclear fuel for more energy extraction.
After the 1995 accident, residents living near the reactor in the Sea
of Japan coastal city and others sued the government to seek a repeal
of the government approval for building the reactor.
The Fukui District Court rejected the demand in 2000, but on Jan. 27,
the Nagoya High Court's Kanazawa branch overturned the lower court
ruling.
In its ruling, the high court supported the plaintiffs' claim that
deficiencies in the government's pre-construction safety checks led
to the 1995 accident and pointed out the plant's structural defects.
The high court decision marks the first time that a Japanese court
has favored plaintiffs seeking a halt to the construction and
operation of nuclear reactors.
--------------
Lab Scandal Hurts U. of Calif. Contract
BERKELEY, Calif. (AP) - The partnership between the government and
the University of California that produced the atomic bomb and the
hydrogen bomb has survived the discovery of a Soviet spy and a $1
billion cost overrun.
Now a fraud scandal at the Los Alamos laboratory has raised questions
about UC's ability to manage the New Mexico lab and led some members
of Congress and other critics to suggest that - after 60 years - it
may be time to put the contract up for bid.
``I made clear to them that, No. 1, their contract is in jeopardy
and, No. 2, one way or another things have to dramatically change
with regards to procurement and management of material at the site,''
said Rep. Jim Greenwood, R-Pa., chairman of the House Energy and
Commerce Committee's oversight and investigations panel, which is
investigating the lab.
The university, on the strength of such faculty stars as J. Robert
Oppenheimer and Ernest O. Lawrence, has run the lab for the
government since it was created during World War II as the
headquarters of the secret Manhattan Project to build the bomb.
In addition to running Los Alamos, UC has managed the Lawrence
Livermore weapons laboratory in Northern California since its
creation in 1952, largely on the initiative of Los Alamos scientist
Edward Teller. But the Livermore contract does not appear to be as
seriously jeopardized.
The relationship between UC and the government has had lots of ups
and downs over the years, and the labs have been rocked by scandal
before - the botched espionage case against Los Alamos scientist Wen
Ho Lee, the $1 billion overrun in Livermore's effort to build a
superlaser, the 1950s unmasking of Los Alamos scientist Klaus Fuchs
as a Soviet spy.
But the latest furor ``may be the biggest challenge yet,'' said Herb
York, a veteran of the labs who headed Lawrence Livermore in the
1950s.
Los Alamos has been rocked by allegations of $2.7 million in missing
computers and other property and widespread misuse of lab-issued
credit cards, including an attempt by a lab employee to buy a souped-
up Ford Mustang for $20,000.
The allegations were compounded by charges of a management cover-up
after two internal investigators who reported the thefts were fired
in November. In recent weeks, the lab director has stepped down, and
other top officials have been reassigned.
Energy Secretary Spencer Abraham has given his staff until April 30
to evaluate UC's performance. UC's contract expires in 2005, but
either side can terminate it at any time.
UC said in a statement that it has taken aggressive action to address
the shortcomings, including instituting a management shake-up.
University officials spent the week in Washington, trying to restore
confidence in their management.
Los Alamos has a budget of $1.7 billion and about 7,500 UC employees.
Under its laboratory-management contracts with the Energy Department,
UC gets $17 million in reimbursement for costs and up to about $18
million in performance-based fees.
The question of whether UC should remain as lab manager has been
coming up for years.
After World War II ended with Hiroshima and Nagasaki laid waste by
Los Alamos scientists' handiwork, UC was reluctant to continue the
partnership. The university has said it manages the labs because the
government wants it to, not because UC wants to.
Despite the occasional clash, the contract has never been put out for
bid. UC has long maintained that it would not compete if that
happened.
With the latest scandal, ``clearly there is a growing sentiment among
many of our members to put the contract out for open bidding,'' said
Ken Johnson, spokesman for the House Energy and Commerce Committee.
Among potential suitors is the University of Texas, which in December
made an unsuccessful bid to run Sandia National Laboratories, and has
Bush administration connections.
Removing UC - at a time when the country is contemplating war with
Iraq - would be a substantial task. The 15,500 UC employees at Los
Alamos and Livermore work on everything from ascertaining if aging
nuclear warheads still work to defending against biological or
chemical attack.
``You have to think about the good of the program and the benefit to
the nation of that program and whether you can move all of the
expertise, which you can't,'' said UC defender Sen. Dianne Feinstein,
D-Calif.
------------------
US urges firms to make "dirty bomb" treatment
WASHINGTON, Jan 31 (Reuters) - The U.S. government on Friday urged
drug companies to begin marketing pills containing Prussian blue, an
artist's pigment used for centuries that can also protect people
exposed to a radioactive "dirty bomb."
The Food and Drug Administration called on pharmaceutical companies
to apply for licenses to market 500-milligram pills of Prussian blue,
or ferric hexacyanoferrate(II), saying it "has been shown to be safe
and effective in treating people exposed to radioactive elements such
as cesium-137."
Health and Human Services Secretary Tommy Thompson said the action
was part of an effort to boost production of drugs that could be used
in the event of another terrorist attack, especially one involving
radioactive materials.
The FDA said Prussian blue, which binds with radioactive particles
and expels them from the body, would be the first therapy available
to decrease radiation exposure. The main side effects were
constipation and stomach upset.
It said the drug could be used to treat patients with known or
suspected internal contamination with radioactive thallium, non-
radioactive thallium, or radioactive cesium.
FDA said cesium-137, found in the fallout from the detonation of
nuclear weapons and in the waste from nuclear power plants, was of
particular concern because it could potentially be use to build a
dirty bomb. Exposure to cesium can cause serious illness and possibly
cancer.
TREATMENT IN BRAZIL
An agency spokeswoman said Prussian blue is produced in the United
States, but not under pharmaceutical standards. She said it has been
used experimentally since the 1960s as an orally ingested drug to
increase fecal excretion of cesium and thallium without it being
absorbed through the intestines.
There are no other FDA-approved treatments for contamination with
thallium or radioactive cesium, FDA said.
Prussian blue was used to treat 250 people in Brazil in 1987 after
they were contaminated with cesium-137 abandoned after use in a
cancer clinic, helping expel the radioactive materials more quickly.
U.S. authorities are holding Jose Padilla, a U.S. citizen who was
captured in May and is accused of plotting with al Qaeda to detonate
such a device.
A so-called "dirty bomb" involves exploding a conventional bomb
wrapped in radioactive material that can kill victims in the
immediate area and spread highly toxic material to humans, causing
mass death and injury.
Prussian blue was first synthesized in 1704 and has been used as an
industrial and artist's pigment since 1724.
-------------------------------------------------
Sandy Perle
Director, Technical
ICN Worldwide Dosimetry Service
ICN Plaza, 3300 Hyland Avenue
Costa Mesa, CA 92626
Tel:(714) 545-0100 / (800) 548-5100 Extension 2306
Fax:(714) 668-3149
E-Mail: sandyfl@earthlink.net
E-Mail: sperle@icnpharm.com
Personal Website: http://sandy-travels.com/
ICN Worldwide Dosimetry Website: http://www.dosimetry.com/
************************************************************************
You are currently subscribed to the Radsafe mailing list. To unsubscribe,
send an e-mail to Majordomo@list.vanderbilt.edu Put the text "unsubscribe
radsafe" (no quote marks) in the body of the e-mail, with no subject line.
You can view the Radsafe archives at http://www.vanderbilt.edu/radsafe/